体外膜氧合过程中动脉血栓复发1例并文献复习。

Q3 Medicine
J Jin, J Liu, L J Xu
{"title":"体外膜氧合过程中动脉血栓复发1例并文献复习。","authors":"J Jin, J Liu, L J Xu","doi":"10.3760/cma.j.cn121090-20241128-00490","DOIUrl":null,"url":null,"abstract":"<p><p>Extracorporeal membrane oxygenation (ECMO) is an advanced technology that provides short-term life support for patients with severe cardiopulmonary failure based on the principle of cardiopulmonary bypass. However, various complications such as acute limb ischemia, osteofascial compartment syndrome, hemorrhage and thrombosis can also occur. A retrospective analysis was performed on a 58-year-old Han male patient with acute myocardial infarction complicated with cardiogenic shock in our department. After the conventional treatment failed, he received urgent VA-ECMO treatment. During this period, arterial thrombosis occurred repeatedly, improved after anticoagulant and antithrombotic treatment, and finally died due to infection. Acute limb ischemia caused by arteriovenous thrombosis is one of the possible serious complications during ECMO treatment. Prevention of thrombosis and optimization of anticoagulant and antithrombotic regimen are the main therapeutic measures. Anticoagulation is still the main treatment method for venous thrombosis during ECMO treatment. Anti-thrombotic drugs are not routinely given during ECMO, while anti-thrombotic drugs are the primary treatment for high-risk arterial thrombosis risk patients. Therefore, early detection of complications and timely intervention are crucial. Early intervention or surgical operation can reduce the incidence of ischemia,improve the survival rate and reduce the disabling outcome.</p>","PeriodicalId":24016,"journal":{"name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","volume":"45 S1","pages":"92-96"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Recurrent arterial thrombosis during extracorporeal membrane oxygenation: a case report and literature review].\",\"authors\":\"J Jin, J Liu, L J Xu\",\"doi\":\"10.3760/cma.j.cn121090-20241128-00490\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Extracorporeal membrane oxygenation (ECMO) is an advanced technology that provides short-term life support for patients with severe cardiopulmonary failure based on the principle of cardiopulmonary bypass. However, various complications such as acute limb ischemia, osteofascial compartment syndrome, hemorrhage and thrombosis can also occur. A retrospective analysis was performed on a 58-year-old Han male patient with acute myocardial infarction complicated with cardiogenic shock in our department. After the conventional treatment failed, he received urgent VA-ECMO treatment. During this period, arterial thrombosis occurred repeatedly, improved after anticoagulant and antithrombotic treatment, and finally died due to infection. Acute limb ischemia caused by arteriovenous thrombosis is one of the possible serious complications during ECMO treatment. Prevention of thrombosis and optimization of anticoagulant and antithrombotic regimen are the main therapeutic measures. Anticoagulation is still the main treatment method for venous thrombosis during ECMO treatment. Anti-thrombotic drugs are not routinely given during ECMO, while anti-thrombotic drugs are the primary treatment for high-risk arterial thrombosis risk patients. Therefore, early detection of complications and timely intervention are crucial. Early intervention or surgical operation can reduce the incidence of ischemia,improve the survival rate and reduce the disabling outcome.</p>\",\"PeriodicalId\":24016,\"journal\":{\"name\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"volume\":\"45 S1\",\"pages\":\"92-96\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn121090-20241128-00490\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121090-20241128-00490","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

体外膜氧合(Extracorporeal membrane oxygenation, ECMO)是一项基于体外循环原理为重症心肺衰竭患者提供短期生命支持的先进技术。然而,急性肢体缺血、骨筋膜室综合征、出血和血栓形成等各种并发症也可发生。回顾性分析我科收治的1例58岁汉族男性急性心肌梗死合并心源性休克患者。在常规治疗失败后,他接受了紧急VA-ECMO治疗。此期间动脉血栓反复发生,经抗凝、抗栓治疗后好转,最终因感染死亡。动静脉血栓形成引起的急性肢体缺血是ECMO治疗中可能出现的严重并发症之一。预防血栓形成和优化抗凝、抗栓方案是主要的治疗措施。在ECMO治疗过程中,抗凝仍然是静脉血栓形成的主要治疗方法。抗血栓药物在ECMO期间不常规使用,而抗血栓药物是高危动脉血栓形成风险患者的主要治疗方法。因此,早期发现并发症并及时干预至关重要。早期干预或外科手术可减少缺血发生率,提高生存率,减少致残结局。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Recurrent arterial thrombosis during extracorporeal membrane oxygenation: a case report and literature review].

Extracorporeal membrane oxygenation (ECMO) is an advanced technology that provides short-term life support for patients with severe cardiopulmonary failure based on the principle of cardiopulmonary bypass. However, various complications such as acute limb ischemia, osteofascial compartment syndrome, hemorrhage and thrombosis can also occur. A retrospective analysis was performed on a 58-year-old Han male patient with acute myocardial infarction complicated with cardiogenic shock in our department. After the conventional treatment failed, he received urgent VA-ECMO treatment. During this period, arterial thrombosis occurred repeatedly, improved after anticoagulant and antithrombotic treatment, and finally died due to infection. Acute limb ischemia caused by arteriovenous thrombosis is one of the possible serious complications during ECMO treatment. Prevention of thrombosis and optimization of anticoagulant and antithrombotic regimen are the main therapeutic measures. Anticoagulation is still the main treatment method for venous thrombosis during ECMO treatment. Anti-thrombotic drugs are not routinely given during ECMO, while anti-thrombotic drugs are the primary treatment for high-risk arterial thrombosis risk patients. Therefore, early detection of complications and timely intervention are crucial. Early intervention or surgical operation can reduce the incidence of ischemia,improve the survival rate and reduce the disabling outcome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
100
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信